Vetter gains approval for new production plant
Vetter Pharma-Fertigung GmbH & Co. KG has received a manufacturing license in accordance with the German Drug Law from the Tuebingen Regional Board for its new state-of-the-art plant Ravensburg Vetter South. After a planning and construction period of only three years and an investment of 100 Million euros, one of the world's most modern production facilities is now ready to begin work.
According to the company, Vetter can offer products of the highest quality, thanks to the highest possible level of automation and an ultra-modern Restricted Access Barrier System. In addition to dual-chamber syringes and cartridges, the new location will enable the company to also fill liquid or lyophilized vials, as well as single-chamber cartridges.
Most read news
Other news from the department manufacturing

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.